新闻专栏

全球领先的基因组学服务供应商GENEWIZ获联合投资

GENEWIZ, a leading global genomics services provider, announced today that it had received an investment to support its growth activities. The terms of the investment were not disclosed. The financing was led by OrbiMed, a healthcare-dedicated investment firm, and participated in by Ampersand Capital Partners and Prime Value Capital Management (PVCM).